scholarly article | Q13442814 |
P50 | author | Gregory D Hussey | Q77719216 |
Cheryl L Day | Q85416307 | ||
W Henry Boom | Q86906278 | ||
Nazma Mansoor | Q117261269 | ||
Gilla Kaplan | Q60908373 | ||
Willem Albert Hanekom | Q71104683 | ||
P2093 | author name string | Tony Hawkridge | |
E Jane Hughes | |||
Marwou De Kock | |||
Bongeka Nqoko | |||
P2860 | cites work | Natural history of vertically acquired human immunodeficiency virus-1 infection. The European Collaborative Study | Q72832300 |
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection | Q24645815 | ||
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome | Q24648628 | ||
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 | ||
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Q29616205 | ||
HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine | Q33627000 | ||
Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants | Q33843438 | ||
Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection | Q33869806 | ||
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1 | Q34545760 | ||
Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression | Q35904453 | ||
Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants | Q36315692 | ||
Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load | Q37009811 | ||
Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment | Q37271461 | ||
Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides | Q37422520 | ||
HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition | Q41966337 | ||
Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes | Q43163152 | ||
Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group | Q44142380 | ||
Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group | Q45746506 | ||
Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus | Q45765734 | ||
HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment | Q46498993 | ||
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load | Q57259602 | ||
Differential Immunogenicity of HIV‐1 Clade C Proteins in Eliciting CD8+and CD4+Cell Responses | Q57259616 | ||
P433 | issue | 12 | |
P921 | main subject | viral load | Q2528140 |
P304 | page(s) | 1311-1316 | |
P577 | publication date | 2011-05-12 | |
P1433 | published in | AIDS Research and Human Retroviruses | Q4651880 |
P1476 | title | HIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral load | |
P478 | volume | 27 |
Q34033051 | Immunity to HIV in Early Life |
Q33813145 | Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles |
Q38037339 | The impact of differential antiviral immunity in children and adults |